HAHussam Abu-Farsakh

Hussam Abu-Farsakh

*This is an algorithmically generated author record based on publicly available information.

Hussam Abu-Farsakh has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Atypical glomus tumors of the lower extremity: a case report of two patients

    by Ahmad Hammad, Yasser Ahmad, Ghaith Abou-Nouar, Hussam Abu-Farsakh, Firas Husban, John Abdelnour

    Introduction and importance: Glomus tumors are rare but clinically significant neoplasms characterized by severe focal pain and a broad anatomic distribution extending well beyond the digits. Extradigital glomus tumors are rare and can lead to prolonged pain and treatment delays; hence, the aim of this study. Case presentation: Patient A, a 51-year-old male, experienced 12 years of refractory anterior right hip pain. MRI revealed an intermediate signal intensity lesion near the intertrochanteric region. Patient B, a 48-year-old male, had 5 years of knee pain with quadriceps atrophy secondary to an adductor canal lesion on MRI. Histopathology revealed uniform, small, round-to-oval cells with a cookie-cutter appearance and pale eosinophilic cytoplasm, which were highly vascular and stained positive for smooth muscle actin. Treatment involved marginal surgical excision, with no signs of recurrence on prolonged follow-up. Clinical discussion: Diagnosis relies on clinical awareness and suspicion, especially in non-resolving and atypical causes of pain and functional limitation, in combination with targeted imaging and confirmatory histopathology. The immunophenotype is crucial in distinguishing a glomus tumor from numerous mimickers. Surgical excision remains curative in most cases, although recurrence can occur when resection is incomplete. Awareness of atypical variants and malignant glomus tumors is essential to ensure proper and timely management. Conclusion: Extradigital, deep-seated glomus tumors are atypical, leading to prolonged diagnostic delays. The diagnostic challenges of extradigital glomus tumors underscore the need for clinical vigilance and timely surgical management.

  • Comparative Evaluation of APAFIX and 10% Formalin for Human Histologic Tissue Preservation: A Pilot Study

    by Nidal A. Qinna, Husam A. Abu-Farsakh, Bayan Y. Ghanim, Ghayda’ AlDabet, Jonathan Earl, Yasmine Mansouri, Sharib S. Muhammad, Qurat-Ul-Ain Siddiqui, Muhammad A. Naseer, Mehwish Mushtaq

    Formalin has long served as the standard fixative in histopathology; however, its limitations—such as antigen masking, nucleic acid degradation, and carcinogenicity—have prompted the search for safer alternatives. APAFIX, a formalin-free fixative, was developed to maintain diagnostic integrity while improving safety in routine tissue handling. This pilot study was conducted to compare the efficiency of the APAFIX solution with formalin in preserving human histologic tissue architecture and cellular morphology as assessed by routine Hematoxylin and Eosin (H and E) staining. Ten human biopsies from different tissue origins underwent standard H and E staining using the routine paraffin technique after 6 to 8 hours of postfixation in either APAFIX or 10% formalin. A blinded pathology review evaluated key histologic parameters, nuclear detail, lymphocyte visualization, fibrous tissue integrity, and overall tissue architecture, using a 10-point scoring system. Results revealed that APAFIX fixing solution was as effective as formalin fixation in terms of tissue quality during processing and sectioning, and in preserving architectural and cellular morphology. APAFIX solution showed enhanced nuclear detail and lymphocyte visualization with occasional fixation artifacts, such as pseudolipomatosis, observed in epithelial tissue. Formalin was more effective in preserving fibrous and epithelial areas. Overall, APAFIX demonstrated sufficient diagnostic performance across the studied pathologic biopsies. APAFIX is a promising formalin-free alternative for histologic tissue fixation, offering enhanced preservation of critical cellular features and eliminating health hazards associated with formalin. Further large-scale studies are warranted to validate its application across broader diagnostic settings and specialized staining techniques.

  • Open Access

    Gene expression alterations in testicular biopsies from males with spermatogenesis arrest identified by transcriptome analysis

    by Osamah Batiha, Esra’a Al-Zoubi, Rowida Almomani, Mohammad A. Al Smadi, Sura Alrawabdeh, Omar Alshokaibi, Hussam Abu-Farsakh, Abedalrhman Alkhateeb, Masood Abu-Halima

    Spermatogenesis is a complex biological process encompasses several stages of cellular divisions, ultimately resulting in producing mature spermatozoa capable of fertilization. Numerous factors involved in the precise regulation of the spermatogenesis, and any disruptions or alterations in these regulatory mechanisms can lead to spermatogenesis arrest, which may result in male infertility. Among these factors, genetic influences play essential role in regulating the process. This study aimed to identify genes that are differentially expressed in relation to spermatogenesis arrest. Testicular biopsy samples were collected from 22 non-obstructive azoospermic patients diagnosed with spermatogenesis arrest (cases) and nine obstructive azoospermic patients (controls). RNA sequencing (RNA-seq) was performed on five samples from the 22 non-obstructive azoospermic patients and compared to previously published transcriptomic data from obstructive azoospermic patients, which served as the control group. Differential expression analysis of the RNA-seq data identified 1,915 differentially expressed genes, comprising 337 upregulated and 1,578 downregulated genes. Among these, several key candidate genes were identified for further analysis, including the upregulation of FOS, FOSB, RGS1, and CXCL8, as well as the downregulation of TNP2, SPRR2C, LINC02314, and C16orf78. RT-qPCR validation confirmed the RNA-seq findings for these genes in the tested samples. Subsequently, RT-qPCR was performed on the remaining 17 non-obstructive (n = 17) and obstructive azoospermic samples (n = 9) collected in this study. The results from these additional samples were consistent with the RNA-seq data, further supporting the findings. Using gene ontology (GO) analysis and published literature, we linked these genes with spermatogenesis arrest, identifying promising targets that could serve as potential biomarkers for this condition in the future.


  • Open Access

    A case of a Jordanian male twin with Cohen's syndrome, with genetic analysis and muscle biopsy; case report

    by Ansam Ghzawi, Hawazen Hirbawi, Ahmad Negida, Hussam Abu-Farsakh

    Introduction and importance Cohen's syndrome is a rare autosomal recessive developmental disorder. It usually presents with a wide variety of muscular, neurological and ophthalmological clinical features. In this report, we present a rare case of the first Jordanian male identical twin with Cohen syndrome with the first ever muscle biopsy results reported. Case presentation: A 20 months old identical male twins were presented for follow up with history of Salam seaziure, muscle dystocia and signs of development delay since five months old. A muscle biopsy and genetic analysis were done accordingly. Under light microscopy, the H&E and Trichome stains sections showed muscle fibers with minimal variation in muscle fiber size. No muscular degeneration, fat replacement, or fibrosis in the periendomysial area. Increased fibroblasts proliferation was seen in between the muscle fibers. The Dystrophy panel including Dystrophin, Dysferlin, Adhalin (alpha 1 sacroglycan) and Emerin showed a normal staining pattern. The heterozygous mutation pattern seen in the vacuolar protein sorting 13 homolog B (VPS13B) gene is a pathogenic variant of Cohen syndrome. The diagnosis was done accordingly. Conclusion: To the best of our knowledge, this is the first case report of Cohen's syndrome from the Jordanian population, and the first muscle biopsy report in a Cohen's syndrome patient ever. This makes a unique educational report and a good guidance for future research in this concern.


  • Open Access

    Low Molecular Weight Chitosan-Insulin Complexes Solubilized in a Mixture of Self-Assembled Labrosol and Plurol Oleaque and Their Glucose Reduction Activity in Rats

    by Amani M. Elsayed, Aseel H. Khaled, Mayyas M. Al Remawi, Nidal A. Qinna, Hussam Abu Farsakh, Adnan A. Badwan

    Oral insulin delivery that better mimics physiological pathways is a necessity as it ensures patient comfort and compliance. A system which is based on a vehicle of nano order where positively charged chitosan interacts with negatively charged insulin and forms a polyelectrolyte complex (PEC) solubilizate, which is then solubilized into an oily phase of oleic acid, labrasol, and plurol oleaque-protects insulin against enzymatic gastrointestinal reduction. The use of an anionic fatty acid in the oily phase, such as oleic acid, is thought to allow an interaction with cationic chitosan, hence reducing particle size. Formulations were assessed based on their hypoglycaemic capacities in diabetic rats as compared to conventional subcutaneous dosage forms. 50 IU/kg oral insulin strength could only induce blood glucose reduction equivalent to that of 5 IU/kg (1 International unit = 0.0347 mg of human insulin). Parameters that influence the pharmacological availability were evaluated. A preliminary investigation of the mechanism of absorption suggests the involvement of the lymphatic route.


  • Open Access

    Differential Expression of Immunohistochemistry Markers for Epithelial/Squamous Cells in Adamantinomatous Craniopharyngioma

    by Hussam AbuFarsakh

    Context: Adamantinomatous cranio pharyngioma (ACP) is an epithelial neoplasm that is located in the sellar regions. It has at least four different squamous histological areas: superficial mature squamous (SMS), stellate reticulum (SR), palisaded basal columnar (PBC) cells and the wet keratin (WK). Design: Twenty two cases of ACP were reviewed from our archives from the period 2005-2012. Immunostainings for cytokeratin 7, cytokeratin 20, cytokeratin 19. high molecular weight cytokeratin (HMWC), low molecular weight cytokeratin (LMWC), epithelial membrane antigens (EMA), cytokeraitn 5/6 and p63 were performed. In addition, immunostainings for p16, p53, Ki-67 and B-catenin were performed. Results: HMWC was positive in all 22 cases in all squamous parts. Cytokeratin 19 was positive in PBC and SR but negative in SMS and WK parts. Cytokeratin 20 was negative in all squamous parts. EMA was positive in SR and WK, but negative in PBC and SMS in 17/22 cases. p63 was positive in PBC and SR cells, but negative in WK and SMS s in 16/22 cases. p16 was positive in PBC and SR in 15/22 cases. Twelve cases show positive p53 immunostainings with range 2%-50% of the cells. Ki67 showed more than 10% positivity in 13 cases, and low positivity or negative in 12 cases. B-catenin was positive in PBC in 11 cases in cytoplasmic and nuclear pattern and was positive in 11 cases in cytoplasmic pattern only. Conclusions: ACP has distinctive patterns of immunostainings for different epithelial and squamous markers. This knowledge helps in diagnosing ACP even in small biopsies and can help to differentiate it from its mimickers.


  • Abstracts and Case Studies From the College of American Pathologists 2017 Annual Meeting (CAP17)

    by Adam L. Booth, MD1; Diana Rodgers, MD2; Phillip Osehobo, MD, PhD2; Lalarukh K. Aftab, MD3; Mahmoud A. Eltorky, MD2; Heather L. Stevenson, MD, PhD11Department of Pathology, University of Texas Medical Branch, Galveston2Department of Pathology, WellStar Spa, Adam L. Booth, Diana Rodgers, Phillip Osehobo, Lalarukh K. Aftab, Mahmoud A. Eltorky, Heather L. Stevenson, Kai Wang, MD, PhD; Rongjun Guo, MD, PhDDepartment of Pathology, University of Alabama at Birmingham., Kai Wang, Rongjun Guo, et al.

    Article Citation: (2017) Abstracts and Case Studies From the College of American Pathologists 2017 Annual Meeting (CAP17). Archives of Pathology & Laboratory Medicine: September 2017, Vol. 141, No. 9, pp. e2-e191. https://doi.org/10.5858/arpa.2017-0238-AB


  • Open Access

    Nestin, an Important Marker for Differentiating Oligodendroglioma from Astrocytic Tumors

    by Hussam AbuFarsakh

    Background: Nestin is an acronym for neuroepithelial stem cell protein. It is an intermediate filament protein expressed in proliferating cells during the developmental stages in a variety of embryonic and fetal tissues. It is also expressed in some adult stem/progenitor cell populations, such as newborn vascular endothelial cell. Differentiation between astrocytic tumors and oligodenoglioma tumor is of paramount importance because of different lines of treatment and different prognosis. Design: We performed Nestin immunostaining on paraffin blocks of 16 cases of astrocytomas of various grades (3 Glioblastoma, 3 anaplastic astrocytoma, 3 fibrillary astrocytoma and 7 Pilocytic astrocytoma) and on 12 oligodendroglioma (6 grade II, and 6 grade III). All cases of oligodendroglioma has confirmation by FISH for 1p 19q. Result: Nestin staining was seen in all astrocytic tumors. The strongest staining was in glioblastomas and in anaplastic astrocytomas. Pilocytic astrocytomas show mostly focal and weak staining with strong staining of Rosenthal fibers. Grade II astrocytoma shows weak but more intense staining than pilocytic astrocytoma. No Nestin immunostaining was seen in any of the oligodendroglioma tumor cells, but Nestin stained the endothelial cells in oligodendroglioma as a positive internal control. Conclusion: Nestin is an important immunohistochemical marker in differentiating oligodendroglioma from astrocytic tumors. Nestin, also, is helpful in grading astrocytoma

  • Open Access

    Morphological and Histochemical Changes in Muscle Biopsies of Myasthenia Gravis with Atypical Clinical Presentation

    by Hussam Abu Farsakh

    The morphological and histochemical changes in muscle biopsies from 6cases with myasthenia gravis (MG) were studied, The patients were misdiagnosed at the initial presentation, however they were all proved later by either histochmical and serological tests or improvement on mestinone therapy to have MG. Here, the histomorphological and histochemical changes that were seen in muscle biopsies of MG with atypical clinical presentation were the followings: atrophy of type II fibers; predominance of type I fibers; increased NADH staining at the neuromuscular junction (NMJ). The most consistent finding is marked reduction in acetylcholinesterease (AChE) activity at the end plates in all cases. The results of this study suggest that histochemical and acetyl cholinesterase stains, in combination with clinical assessment can help to identify unsuspected cases of MG.

  • Open Access

    Morphological and Histochemical Changes in Muscle Biopsies of Myasthenia Gravis with Atypical Clinical Presentation

    by Hussam Abu Farsakh

    The Biomedical Journal of Scientific & Technical Research is an open access medical and clinical research publication that gives acclaimed scientific authors and research experts a global platform to share their work among like-minded peers and help accumulate scientific knowledge in a singular repository.